论文部分内容阅读
目的:比较国产与进口缬沙坦治疗高血压病效果及不良反应。方法:选择原发性高血压病患者98例,其中45例作为观察组,给予进口缬沙坦胶囊;53例作为对照组,给予国产缬沙坦胶囊。两组起始剂量均为80 mg,1次/d,2周后降压效果不佳者,可加量至160 mg,但最大剂量不超过160 mg/d,10周为1个观察疗程。结果:两组服药前至服药后10周,平均收缩压和舒张压均显著下降,但下降幅度比较,差异无统计学意义(P>0.05);两组发生不良反应分别为4例(8.9%)和5例(9.4%),均较轻微,无需停药。结论:国产与进口缬沙坦治疗老年高血压病疗效相同,不良反应发生率差异无统计学意义(P>0.05)。
Objective: To compare the efficacy and adverse reactions of domestic and imported valsartan in the treatment of hypertension. Methods: Ninety-eight patients with essential hypertension were selected as the observation group, valsartan capsules were given as the observation group and 53 as the control group, which were given valsartan capsules. The initial dose of both groups was 80 mg once a day. After 2 weeks, the effect of antihypertensive effect was poor. The dosage could be increased to 160 mg, but the maximum dose did not exceed 160 mg / d. The observation course was 10 weeks. Results: The average systolic pressure and diastolic pressure of two groups were significantly decreased 10 weeks after taking the medicine, but there was no significant difference between the two groups (P> 0.05). There were 4 cases (8.9% ) And 5 cases (9.4%), all of which were minor, without stopping treatment. Conclusion: The efficacy of domestic and imported valsartan in the treatment of elderly patients with hypertension is the same with no significant difference in the incidence of adverse reactions (P> 0.05).